Researchers are exploring the potential of repurposing existing drugs and natural compounds to target proteins associated with the dengue virus, including NS5 and methyltransferase. Studies are using computational methods to identify and analyze potential inhibitors, including phytochemicals and peptide inhibitors, against various dengue virus serotypes and proteins. The research also appears to have implications for treating other related viruses, such as Zika virus.